Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | PF-04136309 |
Trade Name | |
Synonyms | |
Drug Descriptions |
PF-04136309 is a CCR2 antagonist that inhibits CCR2 signaling, resulting in inhibition of tumor progression (PMID: 27055731, PMID: 31297636). |
DrugClasses | |
CAS Registry Number | 1341224-83-6 |
NCIT ID | C97507 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Gemcitabine + Nab-paclitaxel + PF-04136309 | Gemcitabine Nab-paclitaxel PF-04136309 | 0 | 1 |
PF-04136309 | PF-04136309 | 0 | 0 |